PharOS is proud to announce that is the first Greek company to become member of Medicines for Europe (former EGA). Medicines for Europe began over 20 years ago as the European Generics Medicines Association (EGA) with the goal of representing the emerging generic industry, and later growing to include biosimilar medicines to its portfolio. As member of this Association, PharOS will:
- Be part of a strong and united association focused on Generics and Value Added Medicines
- Benefit from joint expertise and access to latest information
- Play part in the sustainability and competitiveness of the pharmaceuticals industries
- Be fully informed on market access, regulatory and legal issues affecting us all
- Enhance its influence at European level
- Network with industry peers